 | • レポートコード：MRC2312MG10626 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のヘパリン市場規模と予測を収録しています。・世界のヘパリン市場：売上、2018年-2023年、2024年-2029年 ・世界のヘパリン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のヘパリン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ナトリウム」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ヘパリンのグローバル主要企業は、Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Pfizer、 Bioibérica、 Changzhou Qianhong Biopharma、 Nanjing King-friend Biochemical Pharmaceutical、 Hebei Changshan Biochemical Pharmaceutical、 Qingdao Jiulong Biopharmaceutical、 Opocrin、 Dongying Tiandong Pharmaceutical、 Aspen Oss、 Yino Pharma、 Nanjing Xinbai Pharmaceutical、 Hubei Enoray Biopharmaceutical、 Cisen Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ヘパリンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のヘパリン市場：タイプ別、2018年-2023年、2024年-2029年 世界のヘパリン市場：タイプ別市場シェア、2022年 ・ナトリウム、カルシウム 世界のヘパリン市場：用途別、2018年-2023年、2024年-2029年 世界のヘパリン市場：用途別市場シェア、2022年 ・UFH、LMWH 世界のヘパリン市場：地域・国別、2018年-2023年、2024年-2029年 世界のヘパリン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるヘパリンのグローバル売上、2018年-2023年 ・主要企業におけるヘパリンのグローバル売上シェア、2022年 ・主要企業におけるヘパリンのグローバル販売量、2018年-2023年 ・主要企業におけるヘパリンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Pfizer、 Bioibérica、 Changzhou Qianhong Biopharma、 Nanjing King-friend Biochemical Pharmaceutical、 Hebei Changshan Biochemical Pharmaceutical、 Qingdao Jiulong Biopharmaceutical、 Opocrin、 Dongying Tiandong Pharmaceutical、 Aspen Oss、 Yino Pharma、 Nanjing Xinbai Pharmaceutical、 Hubei Enoray Biopharmaceutical、 Cisen Pharmaceutical ************************************************************* ・調査・分析レポートの概要 ヘパリン市場の定義 市場セグメント 世界のヘパリン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のヘパリン市場規模 世界のヘパリン市場規模：2022年 VS 2029年 世界のヘパリン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのヘパリンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のヘパリン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ナトリウム、カルシウム ヘパリンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：UFH、LMWH ヘパリンの用途別グローバル売上・予測 ・地域別市場分析 地域別ヘパリン市場規模 2022年と2029年 地域別ヘパリン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Pfizer、 Bioibérica、 Changzhou Qianhong Biopharma、 Nanjing King-friend Biochemical Pharmaceutical、 Hebei Changshan Biochemical Pharmaceutical、 Qingdao Jiulong Biopharmaceutical、 Opocrin、 Dongying Tiandong Pharmaceutical、 Aspen Oss、 Yino Pharma、 Nanjing Xinbai Pharmaceutical、 Hubei Enoray Biopharmaceutical、 Cisen Pharmaceutical ... |
This research report provides a comprehensive analysis of the Heparin market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Heparin market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Heparin, challenges faced by the industry, and potential opportunities for market players.
The global Heparin market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Heparin market presents opportunities for various stakeholders, including UFH, LMWH. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Heparin market. Additionally, the growing consumer demand present avenues for market expansion.
The global Heparin market was valued at US$ 2204.2 million in 2022 and is projected to reach US$ 2960.7 million by 2029, at a CAGR of 7.8% during the forecast period.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
Key Features:
The research report on the Heparin market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Heparin market.
Market Overview: The report provides a comprehensive overview of the Heparin market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Heparin Sodium, Heparin Calcium), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Heparin market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Heparin market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Heparin market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Heparin market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Heparin market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Heparin market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Heparin, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Heparin market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Heparin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Heparin Sodium
Heparin Calcium
Market segment by Application
UFH
LMWH
Global Heparin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Heparin, market overview.
Chapter 2: Global Heparin market size in revenue and volume.
Chapter 3: Detailed analysis of Heparin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Heparin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Heparin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Heparin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Heparin Overall Market Size
2.1 Global Heparin Market Size: 2022 VS 2029
2.2 Global Heparin Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Heparin Sales: 2018-2029
3 Company Landscape
3.1 Top Heparin Players in Global Market
3.2 Top Global Heparin Companies Ranked by Revenue
3.3 Global Heparin Revenue by Companies
3.4 Global Heparin Sales by Companies
3.5 Global Heparin Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Heparin Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Heparin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Heparin Players in Global Market
3.8.1 List of Global Tier 1 Heparin Companies
3.8.2 List of Global Tier 2 and Tier 3 Heparin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Heparin Market Size Markets, 2022 & 2029
4.1.2 Heparin Sodium
4.1.3 Heparin Calcium
4.2 By Type – Global Heparin Revenue & Forecasts
4.2.1 By Type – Global Heparin Revenue, 2018-2023
4.2.2 By Type – Global Heparin Revenue, 2024-2029
4.2.3 By Type – Global Heparin Revenue Market Share, 2018-2029
4.3 By Type – Global Heparin Sales & Forecasts
4.3.1 By Type – Global Heparin Sales, 2018-2023
4.3.2 By Type – Global Heparin Sales, 2024-2029
4.3.3 By Type – Global Heparin Sales Market Share, 2018-2029
4.4 By Type – Global Heparin Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Heparin Market Size, 2022 & 2029
5.1.2 UFH
5.1.3 LMWH
5.2 By Application – Global Heparin Revenue & Forecasts
5.2.1 By Application – Global Heparin Revenue, 2018-2023
5.2.2 By Application – Global Heparin Revenue, 2024-2029
5.2.3 By Application – Global Heparin Revenue Market Share, 2018-2029
5.3 By Application – Global Heparin Sales & Forecasts
5.3.1 By Application – Global Heparin Sales, 2018-2023
5.3.2 By Application – Global Heparin Sales, 2024-2029
5.3.3 By Application – Global Heparin Sales Market Share, 2018-2029
5.4 By Application – Global Heparin Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Heparin Market Size, 2022 & 2029
6.2 By Region – Global Heparin Revenue & Forecasts
6.2.1 By Region – Global Heparin Revenue, 2018-2023
6.2.2 By Region – Global Heparin Revenue, 2024-2029
6.2.3 By Region – Global Heparin Revenue Market Share, 2018-2029
6.3 By Region – Global Heparin Sales & Forecasts
6.3.1 By Region – Global Heparin Sales, 2018-2023
6.3.2 By Region – Global Heparin Sales, 2024-2029
6.3.3 By Region – Global Heparin Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Heparin Revenue, 2018-2029
6.4.2 By Country – North America Heparin Sales, 2018-2029
6.4.3 US Heparin Market Size, 2018-2029
6.4.4 Canada Heparin Market Size, 2018-2029
6.4.5 Mexico Heparin Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Heparin Revenue, 2018-2029
6.5.2 By Country – Europe Heparin Sales, 2018-2029
6.5.3 Germany Heparin Market Size, 2018-2029
6.5.4 France Heparin Market Size, 2018-2029
6.5.5 U.K. Heparin Market Size, 2018-2029
6.5.6 Italy Heparin Market Size, 2018-2029
6.5.7 Russia Heparin Market Size, 2018-2029
6.5.8 Nordic Countries Heparin Market Size, 2018-2029
6.5.9 Benelux Heparin Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Heparin Revenue, 2018-2029
6.6.2 By Region – Asia Heparin Sales, 2018-2029
6.6.3 China Heparin Market Size, 2018-2029
6.6.4 Japan Heparin Market Size, 2018-2029
6.6.5 South Korea Heparin Market Size, 2018-2029
6.6.6 Southeast Asia Heparin Market Size, 2018-2029
6.6.7 India Heparin Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Heparin Revenue, 2018-2029
6.7.2 By Country – South America Heparin Sales, 2018-2029
6.7.3 Brazil Heparin Market Size, 2018-2029
6.7.4 Argentina Heparin Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Heparin Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Heparin Sales, 2018-2029
6.8.3 Turkey Heparin Market Size, 2018-2029
6.8.4 Israel Heparin Market Size, 2018-2029
6.8.5 Saudi Arabia Heparin Market Size, 2018-2029
6.8.6 UAE Heparin Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Shenzhen Hepalink Pharmaceutical
7.1.1 Shenzhen Hepalink Pharmaceutical Company Summary
7.1.2 Shenzhen Hepalink Pharmaceutical Business Overview
7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Major Product Offerings
7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.1.5 Shenzhen Hepalink Pharmaceutical Key News & Latest Developments
7.2 Yantai Dongcheng Pharmaceutical
7.2.1 Yantai Dongcheng Pharmaceutical Company Summary
7.2.2 Yantai Dongcheng Pharmaceutical Business Overview
7.2.3 Yantai Dongcheng Pharmaceutical Heparin Major Product Offerings
7.2.4 Yantai Dongcheng Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.2.5 Yantai Dongcheng Pharmaceutical Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Heparin Major Product Offerings
7.3.4 Pfizer Heparin Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Bioibérica
7.4.1 Bioibérica Company Summary
7.4.2 Bioibérica Business Overview
7.4.3 Bioibérica Heparin Major Product Offerings
7.4.4 Bioibérica Heparin Sales and Revenue in Global (2018-2023)
7.4.5 Bioibérica Key News & Latest Developments
7.5 Changzhou Qianhong Biopharma
7.5.1 Changzhou Qianhong Biopharma Company Summary
7.5.2 Changzhou Qianhong Biopharma Business Overview
7.5.3 Changzhou Qianhong Biopharma Heparin Major Product Offerings
7.5.4 Changzhou Qianhong Biopharma Heparin Sales and Revenue in Global (2018-2023)
7.5.5 Changzhou Qianhong Biopharma Key News & Latest Developments
7.6 Nanjing King-friend Biochemical Pharmaceutical
7.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Summary
7.6.2 Nanjing King-friend Biochemical Pharmaceutical Business Overview
7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Major Product Offerings
7.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.6.5 Nanjing King-friend Biochemical Pharmaceutical Key News & Latest Developments
7.7 Hebei Changshan Biochemical Pharmaceutical
7.7.1 Hebei Changshan Biochemical Pharmaceutical Company Summary
7.7.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Major Product Offerings
7.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.7.5 Hebei Changshan Biochemical Pharmaceutical Key News & Latest Developments
7.8 Qingdao Jiulong Biopharmaceutical
7.8.1 Qingdao Jiulong Biopharmaceutical Company Summary
7.8.2 Qingdao Jiulong Biopharmaceutical Business Overview
7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Major Product Offerings
7.8.4 Qingdao Jiulong Biopharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.8.5 Qingdao Jiulong Biopharmaceutical Key News & Latest Developments
7.9 Opocrin
7.9.1 Opocrin Company Summary
7.9.2 Opocrin Business Overview
7.9.3 Opocrin Heparin Major Product Offerings
7.9.4 Opocrin Heparin Sales and Revenue in Global (2018-2023)
7.9.5 Opocrin Key News & Latest Developments
7.10 Dongying Tiandong Pharmaceutical
7.10.1 Dongying Tiandong Pharmaceutical Company Summary
7.10.2 Dongying Tiandong Pharmaceutical Business Overview
7.10.3 Dongying Tiandong Pharmaceutical Heparin Major Product Offerings
7.10.4 Dongying Tiandong Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.10.5 Dongying Tiandong Pharmaceutical Key News & Latest Developments
7.11 Aspen Oss
7.11.1 Aspen Oss Company Summary
7.11.2 Aspen Oss Business Overview
7.11.3 Aspen Oss Heparin Major Product Offerings
7.11.4 Aspen Oss Heparin Sales and Revenue in Global (2018-2023)
7.11.5 Aspen Oss Key News & Latest Developments
7.12 Yino Pharma
7.12.1 Yino Pharma Company Summary
7.12.2 Yino Pharma Business Overview
7.12.3 Yino Pharma Heparin Major Product Offerings
7.12.4 Yino Pharma Heparin Sales and Revenue in Global (2018-2023)
7.12.5 Yino Pharma Key News & Latest Developments
7.13 Nanjing Xinbai Pharmaceutical
7.13.1 Nanjing Xinbai Pharmaceutical Company Summary
7.13.2 Nanjing Xinbai Pharmaceutical Business Overview
7.13.3 Nanjing Xinbai Pharmaceutical Heparin Major Product Offerings
7.13.4 Nanjing Xinbai Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.13.5 Nanjing Xinbai Pharmaceutical Key News & Latest Developments
7.14 Hubei Enoray Biopharmaceutical
7.14.1 Hubei Enoray Biopharmaceutical Company Summary
7.14.2 Hubei Enoray Biopharmaceutical Business Overview
7.14.3 Hubei Enoray Biopharmaceutical Heparin Major Product Offerings
7.14.4 Hubei Enoray Biopharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.14.5 Hubei Enoray Biopharmaceutical Key News & Latest Developments
7.15 Cisen Pharmaceutical
7.15.1 Cisen Pharmaceutical Company Summary
7.15.2 Cisen Pharmaceutical Business Overview
7.15.3 Cisen Pharmaceutical Heparin Major Product Offerings
7.15.4 Cisen Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.15.5 Cisen Pharmaceutical Key News & Latest Developments
8 Global Heparin Production Capacity, Analysis
8.1 Global Heparin Production Capacity, 2018-2029
8.2 Heparin Production Capacity of Key Manufacturers in Global Market
8.3 Global Heparin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Heparin Supply Chain Analysis
10.1 Heparin Industry Value Chain
10.2 Heparin Upstream Market
10.3 Heparin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Heparin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer